Over-Expression of ARID3B Suppresses Tumor Progression and Predicts Better Prognosis in Patients With Gastric Cancer

BACKGROUND: ARID3B (AT-rich interaction domain 3B) has been demonstrated to be associated with the progression and patient prognosis of several human tumors. We conducted the present study to investigate the biological behavior and clinical relevance of ARID3B in gastric cancer (GC). METHODS: Detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xunlei, Qiu, Xinyue, Zhao, Wenjing, Song, Li, Zhang, Xingsong, Yang, Lei, Tao, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126794/
https://www.ncbi.nlm.nih.gov/pubmed/37071790
http://dx.doi.org/10.1177/10732748231169403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126794/
https://www.ncbi.nlm.nih.gov/pubmed/37071790
http://dx.doi.org/10.1177/10732748231169403

Ejemplares similares